In CPVT, defective regulation of RyR2—often due to mutations in calsequestrin (CASQ2)—is compounded by low Mg2+ levels, worsening the arrhythmic phenotype [157]. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.